PPAG RSS Feed

Early Bird Registration Deadline (Annual Conference) on 5-Aug-10 8:30 AM

Thu, 05 Aug 2010 13:30:00 GMT

Early Bird Registration Deadline (Annual Conference)
Start Date: 5-Aug-10 8:30 AM
End Time: 5-Aug-10 5:30 PM

Neonatal-Resident Small Grant Application Deadline on 15-Sep-10 8:30 AM

Wed, 15 Sep 2010 13:30:00 GMT

Neonatal-Resident Small Grant Application Deadline
Start Date: 15-Sep-10 8:30 AM
End Time: 15-Sep-10 5:30 PM

19th Annual Pediatric Pharmacy Conference and Annual Meeting on 7-Oct-10 12:00 PM

Thu, 07 Oct 2010 17:00:00 GMT

19th Annual Pediatric Pharmacy Conference and Annual Meeting
Start Date: 7-Oct-10 12:00 PM
End Time: 10-Oct-10 12:00 PM
Location: St. Charles Convention Center/Embassy Suites, Saint Charles, MO 63303
Speaker: James Broselow, MD

Event Details:

The Pediatric Pharmacy Conference and PPAG Annual Meeting is designed for practitioners and administrators involved in drug therapy decisions for children. The Meeting is designed by pediatric pharmacists who understand the unique needs of the pediatric patient. This conference will provide important educational benefits for participants who want to improve their positioning in the health care enviornment. It will also provide a new understanding of current medical and clinical trends in pediatric health care.

The overall conference goals are as follows:

Provide and review current information and developments pertaining to pediatric medication use in acute and ambulatory care settings.
Review new technologies that can reduce the risk of errors in the pediatric population.
Discuss new drugs on the market and their application to pediatric patient care.
Provide a forum for the exchange of information and ideas among pediatric practitioners.

About Historic St. Charles

Historic St. Charles, Missouri will host the 19th Annual Pediatric Pharmacy Conference and PPAG Annual Meeting. St. Charles is located in the heart of the Midwest. It is only 20 minutes from downtown St. Louis and only 10 minutes from the St. Louis Lambert International Airport. St. Charles is known for its Historic District which houses over 125 specialty and antique shops along with the 25 quaint restraurants and attractions that line the Missouri River. In St. Charles, you'll walk in the footsteps of Lewis and Clark and exprience part of America's history.

Conference Schedule and Agenda Conference Schedule and Speaker information (HTML) Conference Sessions and CE Objectives (HTML)	Registration Information and Policies To register online, click here. To register via mail or fax, click here Refunds will be given through September 15, 2010. A $25.00 transaction fee will be assessed per refund. After September 15, 2010 no refunds will be given, but balances can be transferred to future meetings or conferences.
Hotel Information- Affordable Rates! PPAG has secured a special room rate of $139.00 per night at the Embassy Suites St. Louis-St. Charles Hotel and Spa. Reservations can be made by calling the Hotel directly at 636-946-5544 or Embassy Suites Brand Reservations at 1-800-EMBASSY. Conference participants must identify themselves as being with the Pediatric Pharmacy Advocacy Group at the time the reservation is made in order to receive the group rate. Reservations must be made on or before September 5, 2010 at 12:00 midnight (central time) to receive the discounted rate. After the cut-off date, reservations will be subject to availability and room-rate increases. PPAG cannot guarantee any reservations after September 5, 2010.	Extras!! PPAG is offering a Preconference Symposium: Cystic Fibrosis: Beyond the Basics. The symposium is partially sponsored by Gilead. For more information, please go to: http://www.ppag.org/ac10-objectives/#CF. Join PPAG as we tour two hospitals in the St. Charles/St. Louis area. St. John's Mercy Hospital and Ranken Jordan Children's Rehabilitation Hospital. For more infromation, please visit: http://www.ppag.org/ac10-objectives/#tour You will be able to register for both or either event during the registration process. The registration fee is $75.00 for each event. The fee includes CE and meals.
Sponsorship Opportunities PPAG offers a variety of opportunities to sponsor the conference. See our Exhibitor Prospectus or contact PPAG for more information at 901-380-3617	Satellite Symposia PPAG offers satellite symposia as a forum for industry-sponsored education programs. Please see our Exhibitor Prospectus or contact PPAG for more information at 901-380-3617.

Conference Credit and Evaluation The Pediatric Pharmacy Advocacy Group is accredited by the American Council for Pharmacy Education as a provider of continuing pharmacy education. The Pediatric Pharmacy Conference is approved to provide 20 contact hours (2 CEU's) for pharmacists. To receive credit participants must attend the session and fill out the online verification of attendance and conference evlauation form. Certificates will be sent 3-4 weeks from the completion of the conference. Prticipants will not receive credit if there is a balance due. PPAG will disclose to participants any financial support received from the pharmaceutical industry during the conference. For more information about ACPE credit information, please contact the PPAG Executive Director.

St. Charles Convention Center/Embassy Suites

Two Convention Center Plaza

Saint Charles, MO USA 63303

20th Pediatric Pharmacy Conference and 2011 Annual Meeting on 16-Mar-11 8:00 AM

Wed, 16 Mar 2011 13:00:00 GMT

20th Pediatric Pharmacy Conference and 2011 Annual Meeting
Start Date: 16-Mar-11 8:00 AM
End Time: 20-Mar-11 12:30 PM
Location: Memphis Marriott Downtown, Memphis, TN 38103

Memphis Marriott Downtown

250 North Main

Memphis, TN USA 38103

We thank Julie Clyce for her years of service!

Matthew Helms — Thu, 29 Jul 2010 15:00:00 GMT

Hello,

Tomorrow we say goodbye to Julie Clyce, our Assistant Director, after four years of service to the Association. No amount of words can express how much she will be missed by all of us.

While at PPAG Julie helped oversee growth in member services and programs. She has provided logistical support at our terrific PPAG conferences. But her biggest contributions, though, are those that are less tangible. No matter the circumstances, she has provided a friendly "front-door" for PPAG. Her positive nature is contagious, especially during committee conference calls and conferences. Bad moods have not lasted very long in the office with her around the office.

While it has been sad and difficult in the office the past few weeks, we send our best wishes to Julie in all future endeavors. She has promised not to be a stranger and will keep in touch with us regularly on Facebook and email!

I invite you to send a quick note to Julie at julie.clyce@ppag.org. I know she will appreciate your words of thanks.

Again, thanks, Julie. You will be missed.

Sincerely,
Matt

Matthew R. Helms, MA, CAE
executive director
ppag

29-Jul-10 10:00 AM

Governing the New PPAG

Michael Christensen — Mon, 26 Jul 2010 20:00:00 GMT

Dear PPAG Members and Friends,

In the 30 year history of PPAG, the association has undergone four bylaw revisions. As PPAG has changed and grown, previous Boards have felt it necessary to amend the bylaws accordingly. Once again, we find ourselves evolving. The New PPAG is dedicated to providing opportunities for members to participate and lead the association. We feel that revising and streamlining our bylaws to provide members with direct representation is necessary. In the latest revision, we have accomplished two important things:

Simplified and streamlined our bylaws to be more consistent with association standards.
Provided membership with the opportunity to directly elect their executive leadership (President-elect, Treasurer, and Secretary).

Simplification of our Bylaws

According to the Association Law Handbook, Bylaws “are used to establish the general organization, and management of the entity needed to achieve corporate existence.” Bylaws provide a broad stroke of the fundamental provisions. After reviewing the Handbook and the bylaws of similar associations, we’ve discovered that our bylaws have described specific policies and procedures more appropriately placed in a Manual of Policies and Procedures. The manual shall provide an administrative guide and a compilation of Board resolutions. For instance, rather than describing the specific procedure in detail for appointing Committee Chairs, the bylaws should simply state that the Board has the authority to appoint Committee Chairs. The appointment process followed should be contained in a separate Policies and Procedures document maintained by PPAG. We are currently working on compiling this Manual and it will be posted on the PPAG website. Policies contained therein will be reviewed after 1-3 years, depending on the policy.

Currently, the standing Committees of PPAG are lead by “Vice Presidents.” Under the revised bylaws, the leaders of Committees shall be referred to as “Committee Chair.” Again, this reflects association standards of governance. Under each standing Committee, sub-committees and ad-hoc task force groups can be formed. The leader of these groups shall be referred to as “Chair,” as well.

Election of Executive Leadership

Currently, PPAG’s leadership is appointed by the Board from members the Board. The membership of the organization does not directly elect the leadership of the organization. We feel this structure is inconsistent with our organizational purpose, mission and values. From a practical perspective, the structure forces individuals that have completed just one year of Board service to become Chair-elect. It is from a humble perspective that the Board amends this process. Now, our President-elect, treasurer, and secretary shall be required to serve one term on the Board. This process will allow potential leaders more time to learn and grow into executive leadership positions. We also believe this will help provide a more mature “institutional” memory for PPAG. Continuity of the Board’s vision and goals is important and difficult to achieve within the current structure.

This summer we will send out a Call for Nominations for the election of officers and at-large directors. The election will take place in the fall.

Final Thoughts: Things NOT motivating the changes

Many organizations, including PPAG, have dealt with financial and other organizational challenges by changing the organizational structure (or bylaws). We do not believe that structural changes will “rescue” PPAG from the current economic climate. However, we do believe that good governance is vitally important to our success. A structure consistent with our values, specifically in the benefits of collaboration and the importance of our experience as members, will indirectly position us to achieve and grow into the future.

We invite you to comment on the new bylaws [Click here to download]. Please feel free to email me at mchriste@uthsc.eduif you have any comments, concerns, or suggestions. We appreciate the time and energy you have given PPAG. Together, we will build the New PPAG.

Sincerely,

Michael Christensen, PharmD, Chair of the Board

26-Jul-10 3:00 PM

2011 Annual Conference Announced

Matthew Helms — Mon, 26 Jul 2010 16:00:00 GMT

PPAG is pleased to announce the location and dates of the 20th Pediatric Pharmacy Conference and 2011 Annual Meeting.

PPAG will be headed to the Home of the Blues, Birthplace of Rock 'n Roll, Memphis, Tennessee. Mark your calendars for March 16-20, 2011. The meeting venue will be the Memphis Marriott Downtown. Room rates will be affordable at $119.00 per night.

We look forward to celebrating 20 years of live education with you in Memphis. This will be the first Annual Meeting offered in the spring.

Features of the Conference will include:

Hematology-Oncology Track
Neonatal Critical Care Track
Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics
Helms Award of Excellence in Pediatric Pharmacy Practice
Best Practice Awards
Young Investigator Award
Best Original Poster
Special Interest Group meetings
Residency Project Presentations
Scientific and Practice Poster sessions
New Practitioner Luncheon

Check out Memphis at www.memphistravel.com.

26-Jul-10 11:00 AM

We're Halfway There!

Matthew Helms — Mon, 26 Jul 2010 14:30:00 GMT

Four weeks into our Campaign for Growth, over sixty (65) PPAG members and friends of the organization have donated over half of our annual fundraising goal! That is $12,300! Some donors have pledged multi-year contributions as well, bringing our total gifts to $23,000 over 5 years.

The following individuals and members have contributed and/or pledged financial support to our Campaign for Growth:

Dr. Cassie Billings

Dr. Kelly Boo

Dr. Jenny Boucher

Dr. Ann Boughner

Dr. Jennifer Bonvechio

Dr. Leslie Briars

Dr. Hollan Buchanon

Dr. Marcia Buck

Dr. Kelly Burch

Mr. Lee Christensen

Drs. Robbin and Michael Christensen

Dr. Cathy Crill

Dr. Robert Daniels

Dr. Cindy Dusik

Dr. Brandon Edgerson

Dr. Lea Eiland

Dr. Sue Erwin

Dr. Elizabeth Farrington

Dr. Allyson Gaylor

Dr. Heather Graham

Dr. Kevin Graner

Dr. David Gregornik

Dr. Allison Grisso

Dr. Emily Hak

Dr. Claudia Hampton
Mr. and Mrs. Matthew Helms

Dr. and Mrs. Richard Helms

Dr. Eilza Hoernle

Dr. David Hoff

Dr. Eliza Hoernle

Dr. Collin Hovinga

Dr. Peter Johnson

Dr. Reginald King

Dr. Kitty Kline

Mr. David Knoppert

Dr. Kathleen Kopcza

Dr. Robert Kuhn

Dr. Bernard Lee

Dr. Kelley Lee

Dr. Jack Lemanowicz

Dr. Jeff Low

Dr. Sherry Luedtke

Dr. Edward Madden

Dr. and Mrs. Bill Maish

Dr. Rachel Meyers

Dr. Jaime Miller

Dr. Marita Nazarian

Dr. Katherine O'Connor

Dr. Michelle Perez

Dr. Curtis Petty

Dr. Stephanie Phelps

Dr. Raul Pino-Lay

Dr. Steven Plogsted

Dr. Amy Potts

Dr. Melissa Ray

Dr. Susan Robbins

Dr. Jasmine Sahni

Dr. Chasity Shelton

Dr. Katherine Smith

Dr. Tara Smith

Dr. Jeremy So

Dr. Jeremy Stultz

Dr. Cheryl Szof

Dr. Emma Tillman

Dr. Tim Todd

Dr. Heather VandenBussche

Dr. Christina Victor

Campaign for Growth: Building the New PPAG Member Contributions
	Received and Pledged	Pledged				Total Donations (Received and Pledged)
Year	2010	2011	2012	2013	2014
Donation Amount	$ 12,300.00	$ 3,175.00	$ 2,675.00	$ 2,425.00	$ 2,425.00	$ 23,000.00

Join your colleagues and be one of the many builders of PPAG. Donate today at http://ppag.org/en/donations/!!!

For more information about our Campaign for Growth, visit the website at http://www.ppag.org/campaign-for-growth.

26-Jul-10 9:30 AM

RSV Prevention Clinic Wins 2010 PPAG Best Practice Award

Matthew Helms — Thu, 22 Jul 2010 19:00:00 GMT

Jennifer Chow, Michael Chicella, Anthony Christensen, Eloise Woodruff, Mital Desai, Carolyn Moneymaker, John Harrington, and James Dice at the Children's Hospital of the King's Daugther (CHKD) in Norfolk Virginia are recognized for the establishment of a pharmacist-managed RSV Prevention Clinic. The group was selected from thirty (30) submissions.

Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and pneumonia in infants. It is also the leading cause of hospitalizations in infants less than a year in the United States. Palivizumab is an RSV-specific monoclonal antibody that is administered once a month during RSV season to prevent RSV infection that requires hospitalization. Non- compliance with the dosing regimen appears to be the factor commonly associated with drug failure. Studies of other pharmacist managed clinics have demonstrated that pharmacists can increase compliance and therefore improve patient outcomes.

During the 2009-2010 RSV season, a pharmacist-managed RSV Prevention Clinic was established in the General Academic Pediatrics clinic at CHKD. Once eligible patients were identified the pharmacist contacted the parents/caregivers and set up an appointment to receive palivizumab. During the appointment the pharmacist was responsible for providing education on RSV, importance of receiving palivizumab, and steps to decrease RSV exposure and transmission. The pharmacist administered palivizumab to the patient and when necessary triaged the patient to see other health-care professionals. In order to determine the impact of this clinic on patient compliance we compared data from the 2008-2009 RSV season (group 1) which was prior to the establishment of the pharmacist-managed clinic to data compiled from the 2009-2010 RSV season (group 2). Group 2 data was after the pharmacist-managed clinic was established. Data compared included demographic data, number of shots administered, RSV testing, and RSV hospitalizations (>24 hours in hospital). Compliance was determined as the number of patients who received eligible doses in consecutive months.

As a result, compliance with palivizumab dosing increased. RSV infections and hospitalizations decreased by over 50%.

[Eighty-six infants were identified as palivizumab eligible in group 1 and 75 infants were eligible in group 2. Sixty-seven infants (78%) in group 1 receive at least one dose of palivizumab, whereas 71 patients (95%) in group 2 received at least one dose of palivizumab. Nineteen infants (28%) in group 1 received all doses of palivizumab as compared to 63 infants (89%) in group 2 (p<0.01). With regard to compliance, only 18 patients (27%) in group 1 received all eligible doses in consecutive months as compared to 60 patients (85%) in group 2 (p<0.01). In group 1, eight patients developed RSV and 5 of those required hospitalization. In group 2, three patient developed RSV and one of those required hospitalization.]

The Best Practice Award lecture will be given at the 19th Pediatric Pharmacy Conference and PPAG Annual Meeting in St. Charles, Missouri on October 8, 2010 at 9:00 am. The PPAG Best Practice Award is sponsored by Lexi-Comp.

22-Jul-10 2:00 PM

PPAG Annual Conference Registration is Open.

Matthew Helms — Tue, 20 Jul 2010 20:13:04 GMT

Visit the conference website at: http://www.ppag.org/en/cev/43.

The overall conference goals are as follows:

Provide and review current information and developments pertaining to pediatric medication use in acute and ambulatory care settings.
Review new technologies that can reduce the risk of errors in the pediatric population.
Discuss new drugs on the market and their application to pediatric patient care.
Provide a forum for the exchange of information and ideas among pediatric practitioners.

About Historic St. Charles

Conference Schedule and Agenda Conference Schedule and Speaker information (HTML) Conference Sessions and CE Objectives (HTML) Early Bird Deadline is August 5, 2010.	Registration Information and Policies To register online, click here. To register via mail or fax, click here Refunds will be given through September 15, 2010. A $25.00 transaction fee will be assessed per refund. After September 15, 2010 no refunds will be given, but balances can be transferred to future meetings or conferences.
Hotel Information- Affordable Rates! PPAG has secured a special room rate of $139.00 per night at the Embassy Suites St. Louis-St. Charles Hotel and Spa. Reservations can be made by calling the Hotel directly at 636-946-5544 or Embassy Suites Brand Reservations at 1-800-EMBASSY. Conference participants must identify themselves as being with the Pediatric Pharmacy Advocacy Group at the time the reservation is made in order to receive the group rate. Reservations must be made on or before September 5, 2010 at 12:00 midnight (central time) to receive the discounted rate. After the cut-off date, reservations will be subject to availability and room-rate increases. PPAG cannot guarantee any reservations after September 5, 2010.	Extras!! PPAG is offering a Preconference Symposium: Cystic Fibrosis: Beyond the Basics. The symposium is partially sponsored by Gilead. For more information, please go to: http://www.ppag.org/ac10-objectives/#CF. Join PPAG as we tour two hospitals in the St. Charles/St. Louis area. St. John's Mercy Hospital and Ranken Jordan Children's Rehabilitation Hospital. For more infromation, please visit: http://www.ppag.org/ac10-objectives/#tour You will be able to register for both or either event during the registration process. The registration fee is $75.00 for each event. The fee includes CE and meals.
Sponsorship Opportunities PPAG offers a variety of opportunities to sponsor the conference. See our Exhibitor Prospectus or contact PPAG for more information at 901-380-3617	Satellite Symposia PPAG offers satellite symposia as a forum for industry-sponsored education programs. Please see our Exhibitor Prospectus or contact PPAG for more information at 901-380-3617.

Conference Credit and Evaluation The Pediatric Pharmacy Advocacy Group is accredited by the American Council for Pharmacy Education as a provider of continuing pharmacy education. The Pediatric Pharmacy Conference is approved to provide 20 contact hours (2 CEU's) for pharmacists. To receive credit participants must attend the session and fill out the online verification of attendance and conference evlauation form. Certificates will be sent 3-4 weeks from the completion of the conference. Prticipants will not receive credit if there is a balance due. PPAG will disclose to participants any financial support received from the pharmaceutical industry during the conference. For more information about ACPE credit information, please contact the PPAG Executive Director.

20-Jul-10 3:13 PM

JPPT Apr-Jun 2010 Available Online

Matthew Helms — Fri, 16 Jul 2010 13:00:00 GMT

The April-June 2010 issue of the Journal of Pediatric Pharmacology and Therapeutics is now available online for subscribers and PPAG members.

Volume 15 Number 2 (April-June 2010)

Table of Contents

Editorials

Switching of Antiepileptic Drug Formulations
J. Nile Barnes, PharmD and Karen L Rascati, PhD

A Patient’s Voice

Stephanie J. Phelps, PharmD

Helms Award Lecture

Interplay Between Pediatric Pharmacy Practice and Research to Influence Patient Care
Milap C. Nahata, PharmD, MS

Special Article

The History of PPAG: The First 30 Years
Robert L. Poole, PharmD

Review Articles

The Controversy over Generic Antiepileptic Drugs
Susan J. Shaw, MD and Adam L. Hartman, MD

Pharmacokinetics and Drug Dosing in Obese Children
Jennifer G. Kendrick, PharmD, Roxane R. Carr, PharmD, and Mary H.H. Ensom, PharmD

Clinical Investigation

Plasma Amino Acid Concentrations in 108 Children Receiving a Pediatric Amino Acid Formulation as Part of Parenteral Nutrition
Chasity M. Shelton, PharmD, Amanda J. Clark, PharmD, Michael C. Storm, PhD, and Richard A. Helms, PharmD

Effects of Age and Weight-Based Dosing of Enoxaparin on Anti-Factor Xa Levels In Pediatric Patients
Lela S. Fung, PharmD and Christopher Klockau, BScPharm

Pharmacists’ Attitudes Towards Pediatric Cough and Cold Products and Behind the Counter Status
Sally A. Huston, PhD, Kalen B. Porter, PharmD, Tom Clements, PharmD, and Greene Shepherd, PharmD

Stability of Ziprasidone Mesylate in an Extemporaneously Compounded Oral Solution
Kelsey Green, PharmD and Roy C. Parish, PharmD

Brief Report

Opioid Infusions in the Neonatal Intensive Care Unit
Amanda Suarez, BScPharm, ACPR, David C. Knoppert, MScPharm, MSc, David S. C. Lee, BS, MB, FRCPC, Donna Pletsch, RN, MN, and Jamie A. Seabrook, MA

CLICK HERE FOR ARTICLES

16-Jul-10 8:00 AM

Introducing our Campaign for Growth

Michael Christensen — Thu, 01 Jul 2010 16:45:00 GMT

Dear PPAG Member and Supporter,

I am writing you as the President of PPAG. Many of you may be unaware how tenuous a position PPAG finds itself in during this difficult recession.

For many years, PPAG benefited from the generous support of the pharmaceutical industry. In fact, industry support accounted for 30%-40% of our average $375,000 budget. Over the years, PPAG managed to allocate moneys to a reserve fund. There have been significant changes in how Industry interacts with professional health care associations, and it is clear that we can no longer count on this support in the future.

Perhaps you have had to decide on or felt the impact of clinics, hospitals and universities reduction in travel and professional development budgets. The “trickle-down” effect has resulted in decreased participation in our live educational programs, which accounts for as much as 40% of our operating budget.

I am happy to report that previous and current volunteer leaders and professional staff have been good stewards of our resources. Over the past eight years, PPAG slowly funded a reserve fund for a rainy day. Unfortunately, that rainy day has arrived. We are currently using our rainy day funds to meet our operational needs. While our reserve fund is helping us meet our operational costs, we can not continue to rely on reserve funds since they will only sustain us for 12 months based on current expenditures.

Rest assured in response to these challenging conditions, the Board has taken action carefully and quickly. We have focused on three things:

Controlling operational expenditures. We have reduced the fixed cost of the organization by nearly $175,000 per year. We have eliminated expenditures of supplies, travel, leases, and insurances. As of July 31, PPAG will be a “virtual” organization. The Board has also made a very difficult decision to reduce full time staff support. Julie Clyce, our Assistant Director for the past three years, has been a tremendous asset for PPAG. She has helped us through tremendous growth in membership services. Julie's service to PPAG is appreciated by all of us.

Exploring new business models and revenue opportunities. One of the most promising new avenues for income has been our partnership with Zolstice, LLC to develop, promote, and deliver a standardized approach to acute pediatric medication therapy. Also, expansion of our educational programming into the community setting promises an exciting new opportunity for PPAG. Both new initiatives serve as a way for PPAG to expand membership and its influence on pediatric practice from institutional practice to community practice.

Developing a long term agenda for future success and growth. With this letter, we launch our new Campaign for Growth: Building the New PPAG. This campaign is member-focused and member-driven. We believe that PPAG has a solid foundation that will spark the necessary changes to get us through these challenging times. The Campaign website www.ppag.org/campaign-for-growth/ explains our agenda and how you can help.

We are the sole pediatric pharmacy organization in the country today. I know I am preaching to the choir, but the importance of PPAG cannot be understated. PPAG delivers value through our networking of members, our educational programming, and most importantly as a voice for safe and effective use of medications in children in the adult-dominated pharmacy world. We are increasingly being looked to lead pediatric pharmacy around the world. I surveyed other pharmacy meetings, and found few pediatric educational offerings. In fact it would take four years to find the equivalent amount of pediatric CE in other pharmacy organizations to equal what can be found in just one PPAG annual meeting.

On behalf of the PPAG Board, I hope that the “Campaign for Growth” website will provide you a sense of our new direction and give you ideas on how you can contribute.

Let's put on our hard hats and build the New PPAG!

With Warmest Regards,

Michael Christensen, PharmD
President

1-Jul-10 11:45 AM

Reed to Receive 2010 Yaffe Award

Thu, 17 Jun 2010 16:00:00 GMT

Michael D. Reed, PharmD, has been selected as the 2010 Yaffe Award winner. The award is given in recognition of significant and sustained contributions toward the improvement of children’s health through the expansion of the field of pediatric pharmacology and therapeutics.

Dr. Reed is Director of the Rebecca D. Considine Clinical Research Institute and the Division of Clinical Pharmacology and Toxicology, Children’s Hospital Medical Center of Akron (CHMCA). Dr. Reed is Professor and Associate Chair, Department of Pediatrics, Northeastern Ohio Universities College of Medicine and Pharmacy (NEOUCOM). Dr. Reed received his Bachelor of Science degree in Pharmacy and post-baccalaureate Doctor of Pharmacy degree from the University of Cincinnati. While obtaining his doctorate he concurrently served a clinical pharmacology residency in pediatrics at the Children’s Hospital Medical Center, Cincinnati.

Dr. Reed’s research interests focus on the developmental pharmacology and toxicology of drugs in humans and how these data translate into the design of optimal dosing regimens for use in infants, children, and adults. He has extensive research experience in the design, implementation, and analysis of pharmacokinetic, pharmacodynamic and pharmacogenomic interrelationships as they relate to the maturing infant, child and adolescent. Dr. Reed has authored more than 200 published works describing his original research activities, invited reviews and book chapters.

Dr. Reed will present the Yaffe Award Lecture on October 8, 2010 during the 19th Pediatric Pharmacy Conference.

17-Jun-10 11:00 AM

Kuhn to receive 2010 Helms Award

Thu, 17 Jun 2010 16:00:00 GMT

Robert Kuhn, PharmD has been selected as the 2010 recipient of the Helms Award for Excellence in Pediatric Pharmacy Practice. The award recognizes sustained and meritorious contributions to PPAG and to pediatric pharmacy practice, and contributions of importance to education, new knowledge, and outreach.

Dr. Kuhn is currently professor of pharmacy practice and science at The University of Kentucky College of Pharmacy. He holds a joint appointment as professor in the department of pediatrics and is a pediatric clinical specialist at Kentucky Children’s Hospital and serves as Associate director of Pharmacy services. Before joining the faculty in 1985, he received a Bachelor of Arts degree in philosophy from the University of Steubenville (Ohio) and Bachelor of Science degree in pharmacy from The Ohio State University. His doctor of pharmacy degree was obtained in 1984 from the University of Texas at Austin. He completed a pediatric fellowship at Columbus Children’s Hospital in 1985 under the direction of Milap Nahata.

Dr. Kuhn’s research and clinical practice has centered on pulmonary drug delivery and drug therapy in patients with cystic fibrosis. He has participated in many clinical trials of new drug therapies for patients with CF over the last 25 years and helped develop and evaluate new therapies for this disease. He has over 60 publications and help organize pharmacists involved in the care of patients with cystic fibrosis.

He currently serves as program director of the pediatric pharmacy residency program at UK and he has mentored over 30 specialty residents since joining the faculty. He has served on the Board of PPAG for seven years and served two years as President, as well as Immediate Past President and currently is Vice President for Finance for PPAG. He has received numerous awards including a membership in the National Academies of Practice and the Doug Jones Teaching Award from Dartmouth for his work in cystic fibrosis education.

The Helms Award Lecture will be given by Dr. Kuhn on October 11, 2010 at the 19th Annual Pediatric Pharmacy Conference.

17-Jun-10 11:00 AM

Pharmacotherapy Specialist

Fri, 23 Jul 2010 05:00:00 GMT

Title: Pharmacotherapy Specialist Description: Lexi-Comp's clinical team seeks a pediatrics-trained pharmacist to join our in-house professional staff to help support content development within our drug information databases. The successful candidate will be expected to contribute expertise reflective of contemporary pediatric practice, to assist in the development and review of practice-relevant content within our pediatric drug information databases. A secondary function will involve participating in the drafting and editorial review process of general (ie, non-pediatric) drug monograph content across all therapeutic disciplines. Required Experience: The successful candidate is a pharmacist with a minimum of five years of pediatric clinical practice experience and strong writing skills. Additionally, ideal candidates will have residency training or equivalent significant pediatric practice experience. Pharmacists also possessing demonstrable oncology experience will...

Clinical Pharmacy Specialist - Pediatrics

Wed, 21 Jul 2010 05:00:00 GMT

Title: Clinical Pharmacy Specialist - Pediatrics Description: Amherst Healthcare, a Leader in Pharmacist recruitment is currently seeking a Clinical Pediatrics Pharmacist for a top-notch, world class medical center in New York City. You've heard the city in multiple songs, everyone in the world knows of New York. You've even heard Sinatra sing that if you can make it there...you can make it anywhere! How about living, working and playing in the city that never sleeps. How about working at one of the best medical centers in the world? If you've ever had dreams of walking down the busy streets of Manhattan or catching a cab or even a subway then this might be the position you've been waiting for. If you've ever wanted to hang out at Rockefeller Center in the winter and watch people ice skate, or see the taping of Good Morning America live, this just might be that offer that you can't refuse. If you enjoy culture, theater and just the atmosphere of...

Clinical Staff Pharmacist

Tue, 20 Jul 2010 05:00:00 GMT

Title: Clinical Staff Pharmacist Description: Clinical Staff Pharmacist Memphis, TN St. Jude Children's Research Hospital, located in Memphis, Tennessee, is a premier center for research and treatment of potentially fatal childhood diseases, including cancer and certain blood, genetic, and immunodeficiency disorders. The hospital's mission is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. St. Jude is dedicated to providing unsurpassed patient care and to advancing the health of children through biomedical research. Currently, St. Jude Children's Research Hospital currently has an opening for a Clinical Staff Pharmacist (Job Number 18677). The Clinical Staff Pharmacist is primarily responsible for all drug distribution and control activities, evaluating, processing, and monitoring prescriber orders for patient medications and other pharmaceutical supplies, provision of drug information,...

STAFF PHARMACIST II - Pediatrics

Thu, 24 Jun 2010 05:00:00 GMT

Title: STAFF PHARMACIST II - Pediatrics Description: STAFF PHARMACIST II - Pediatrics UCSF Medical Center is a 706 bed tertiary care teaching hospital that includes a 150 bed Children's Hospital. An opportunity currently exists for a Pediatric Clinical Pharmacist at the University of California San Francisco Children's Hospital. This hybrid position will consist of 4 to 6-week clinical and distribution rotations. Responsibilities during the clinical rotation include daily rounds on a multi-disciplinary team, floor order entry activities, medication reconciliation, discharge facilitation, and precepting students and residents. The clinical pharmacist will be involved with direct patient care activities. While working closely with the medical, nursing, and pharmacy staff, the clinical pharmacist will develop and maintain services to improve patient care, reduce cost, reduce medication errors, and improve efficiencies. The distribution rotation will consist of staffing in...

Our Campaign for Growth

Tue, 27 Jul 2010 20:43:53 GMT

Welcome to our Campaign for Growth: Building the New PPAG website. Please see an open letter from our President, Michael Christensen, PharmD. Campaign Quick Links Challenges and Project Specs Our Foundation Framing the New PPAG Our Builders Progress-to-Date Facing new challenges seems to be a common refrain the last few years. Every sector of our national economy has been affected by the great recession. Pay-for- performance is a reality for health care reimbursements. Pharmacies and colleges are experiencing budget cuts. Yet, it is also a thrilling time to be in pharmacy practice as new technology, knowledge, and service models emerge. Fortunately, as pediatric pharmacists, we are experienced in navigating through challenges to benefit our pediatric patients. PPAG is not immune from these economic pressures and changes in our health care system. We have reached a critical point in the financial viability of...

Current Issue Cover

Fri, 16 Jul 2010 12:51:46 GMT

Volume 15 Number 2 (April-June 2010) CLICK HERE Editorials Switching of Antiepileptic Drug Formulations J. Nile Barnes, PharmD and Karen L Rascati, PhD A Patient's Voice Stephanie J. Phelps, PharmD Helms Award Lecture Interplay Between Pediatric Pharmacy Practice and Research to Influence Patient Care Milap C. Nahata, PharmD, MS Special Article The History of PPAG: The First 30 Years Robert L. Poole, PharmD Review Articles The Controversy over Generic Antiepileptic Drugs Susan J. Shaw, MD and Adam L. Hartman, MD Pharmacokinetics and Drug Dosing in Obese Children Jennifer G. Kendrick, PharmD, Roxane R. Carr, PharmD, and Mary H.H. Ensom, PharmD Clinical Investigation Plasma Amino Acid Concentrations in 108 Children Receiving a Pediatric Amino Acid Formulation as Part of Parenteral Nutrition Chasity M. Shelton, PharmD,...

Current Issue

Fri, 16 Jul 2010 12:20:11 GMT

Next Issue

Volume 15 Number 3 (July-Sept 2010) expected in September 2010

Introducing our Campaign For Growth: Building the New PPAG

Wed, 30 Jun 2010 15:40:39 GMT

June 25, 2010 Dear PPAG Members and Supporters, I am writing you as the President of PPAG. Many of you may be unaware how tenuous a position PPAG finds itself in during this difficult recession. For many years, PPAG benefited from the generous support of the pharmaceutical industry. In fact, industry support accounted for 30%-40% of our average $375,000 budget. Over the years, PPAG managed to allocate moneys to a reserve fund. There have been significant changes in how Industry interacts with professional health care associations, and it is clear that we can no longer count on this support in the future. Perhaps you have had to decide on or felt the impact of clinics, hospitals and universities reduction in travel and professional development budgets. The “trickle-down” effect has resulted in decreased participation in our live educational programs, which accounts for as much as 40% of our operating budget. I am happy to report that previous and current volunteer...

homepage 1

Wed, 30 Jun 2010 15:22:16 GMT

- KidsMeds is your online resource for pediatric medication information. PPAG offers many benefits to pediatric pharmacists. Here are just a few: Subscription to the Journal Access to PediNet Discounted registration fees to educational meetings More To join PPAG or renew your membership, simply fill out the online application form or for other methods view our join page. View Membership FAQ's

homepage - conference info

Sun, 20 Jun 2010 21:33:44 GMT

19th Pediatric Pharmacy Conference
Featuring James Broselow, MD

Embassy Suites St. Louis-St. Charles Hotel and Spa
Saint Charles, Missouri
October 7-10, 2010

19th Pediatric Pharmacy Conference and 2010 Annual Meeting Agenda

Tue, 08 Jun 2010 18:50:47 GMT

Thursday, October 7, 2010 Time Topic Speaker 8:00-11:00am Pre-Conference – Cystic Fibrosis 11:30-12:30pm New Practitioner Networking Lunch 19th Pediatric Pharmacy Conference and Annual Meeting Begin 12:30-2:00pm Level 1 – PICU Resuscitation and RSI Pharmacotherapy Melissa Hunt, PharmD Level 2 – NICU Neonatal Abstinence Syndrome Peter Gal, PharmD General Wrkshp Anticoagulation Cyrine Haidar, PharmD 2:00-2:15pm Break 2:15-3:45pm Level 1 – PICU Approach to a Complicated Patient Kelly Kopec, PharmD Level 2 – NICU Neonatal Circulatory Support Christopher McPherson General Wrkshp Management of Pulmonary Hypertension Cortney Rogers, PharmD 3:45-4:00pm Break 4:00-5:00pm Keynote Address James Broselow, MD 5:00-5:30pm PPAG Fellows Awards 5:30-6:30pm Fellows and Opening Reception Friday, October 8, 2010 Time Topic Speaker 8:00-9:00am Sumner J. Yaffe...

Online CE Programs

Tue, 25 May 2010 20:36:49 GMT

Welcome to PPAG Education Central, your one-stop-shop for home-based pediatric educational programs. We are pleased to offer group purchasing rates to institutions (hospitals and pharmacies). Please go to: http://www.ppag.org/CEgrouprate/ for more information. Pediatric Age-Based Competencies For more information about Aged-based Competency Series, please click here. TITLE HRS. ACPE # PRICE Physiologic and Pharmacokinetic Differences in Children, Fluids and Electrolytes and Dehydration in Children 2.5 0180-0000-08-002-H04-P MEM: $10.00 NonMEM: $30.00 Respiratory Syncytial Virus: Diagnosis, Treatment and Prevention 1 0180-0000-09-001-H01-P MEM: $5.00 NonMEM: $15.00 Bronchopulmonary Dysplasia: Diagnosis, Prevention, and Treatment 1 0180-0000-09-002-H01-P MEM: $5.00 NonMEM: $15.00 Management of Asthma Exacerbations 1 0180-0000-09-003-H01-P MEM: $5.00 NonMEM: $15.00 DKA & HHS 1 0180-0000-09-100-H01-P MEM: $5.00...

Christensen Memorial Young Investigator Award

Thu, 06 May 2010 16:38:53 GMT

The Christensen Memorial Young Investigator Award is available to investigators who have been in practive five (5) years or less . This award will be granted to the investigator based on their written abstract and the quality of their poster presentation at the PPAG Annual Meeting each year.

The Award is named in memory of Joyce and Lloyd Christensen, the parents of Michael Christensen, PharmD, the 2009-10 Chair of the PPAG Board. Family, friends and colleagues of Dr. Christensen generously funded the award in memory of Dr. Christensen's parents, who past away during his term as Board Chair.

Call for Research/Scientific Abstracts will be sent in the summer each year.

Previous Recipients of the Young Investigator Award:

2009:

2008: Kimberley Pesaturo
2007:

2006: Ruston Taylor

2005: Marlow Hanson

2004:

To donate to the Christensen Memorial Young Investigator Award Fund, please click here. Please designate "Christensen Fund" in the comment section to properly ensure your funds are used as intended.

Join PPAG or Renew Your Membership

Wed, 28 Apr 2010 17:44:15 GMT

PPAG membership represents pediatric pharmacists and associates who practice in free-standing children's hospitals, university hospitals, community hospitals, non-university teaching hospitals, home care facilities, schools of pharmacy, neonatal intensive care units and clinics.

There are presently approximately 700 active members from the United States, Canada, Australia, United Kingdom, France, and Spain. Ninety-four percent of the members are in the United States.

The 3 Methods to Join PPAG or Renew your Membership!

Fill out our online application form. We accept online payment. Visa, Master, and AMEX.

NOTE: If you would like to become a student member, you must also fill out our student verification form.
If you prefer to send the form and payment via US Mail, please print the form, and send to PPAG Administrative Offices at 7953 Stage Hills Blvd. Ste. 101, Memphis, TN. 38133.
Over the phone. Just call, (901) 380-3617, and a PPAG representative will assist you.

Acthar Gel (repository corticotrophin injection) Survey

noemail@ppag.org — Mon, 26 Feb 2007 17:00:00 GMT

Objectives:

This is a survey for pharmacies that order Acthar Gel (repository corticotrophin injection). The product is currently indicated for the treatment of acute exacerbations of multiple sclerosis and other conditions, and it is used off-label for treatment of infantile spasms. The maker of Acthar Gel, Questcor, filed a supplemental new drug application for the infantile spasms indication in August 2006. The company is now trying to understand how much of Acthar Gel usage is for multiple sclerosis and how much is for infantile spasms.

PPAG has received a small grant to conduct this survey.

Release Date: 26-Feb-07 11:00 AM
Expiration Date: 10-Apr-07 4:00 PM

if you use Acthar Gel, please fill out the survey to the best of your ability. Please coordinate within your institution so we do not receive duplicate information. We are not asking for facility name or participant information (involuntarily) in order to ensure confidentiality.

Medication Administration in Schools

noemail@ppag.org — Wed, 12 Jul 2006 19:00:00 GMT

Objectives:

We are looking to identify challenges and or cases within local school system or daycare settings.

For example: "Johnny’s" school doesn’t have a nurse, the school refuses to allow any medication administration, and so a parent goes to school everyday to administer!

The results of this survey will be presented at the 15th Annual Meeting during the Advocacy Workshop.

Release Date: 12-Jul-06 2:00 PM
Expiration Date: 10-Sep-06 2:00 PM
Please read and respond to the following questions.

What are your thoughts about PediNet?

noemail@ppag.org — Tue, 08 Nov 2005 15:00:00 GMT

Objectives: The Membership Services Committee values your opinion about the services PPAG provides its members. This survey was created to get your feedback about our PediNet Member Forums.

Release Date: 8-Nov-05 9:00 AM
Expiration Date: 14-Apr-06 9:00 AM
Please answer the questions provided. There are only 8 questions to answer. It should not take that long to complete.

2006-07 Educational Needs Assessment

noemail@ppag.org — Thu, 06 Oct 2005 02:00:00 GMT

Objectives: To better understand the continuing educational needs of our members.

Release Date: 5-Oct-05 9:00 PM
Expiration Date: 3-Jan-06 9:00 PM

Please offer comments in the text boxes provided.

Antifungal Survey for Stem Cell Transplantation/ Hematology-Oncology

noemail@ppag.org — Thu, 30 Jun 2005 21:00:00 GMT

Objectives:

To evaluate the use of antifungal agents in the pediatric hematology-oncology (H/O) and 

stem cell transplant (SCT) population and to assess differences in practice among various 

institutions.

Release Date: 30-Jun-05 4:00 PM
Expiration Date: 30-Mar-06 4:00 PM
Please participate in the following survey. Any PPAG member or affiliate can take the survey. Please coordinate your response within your institution to avoid duplicity.

To climb steep hills, requires slow pace at first.

Tue, 21 Jun 2005 23:24:19 GMT

"To climb steep hills, requires slow pace at first."

William Shakespeare, Henry VIII

Core Competency Series: Pediatric Parenteral Nutrition

2010-03-19T13:00:00Z

Instructor: Kathleen Gura, PharmD

This program is a one hour Power Point presentation with synched audio. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the course handout (PDF), click here. After completion of the program, you may take the post-test to receive credit. gura ppag 2008 with audio See more presentations by mrhelms | Upload your own PowerPoint presentations

Extreme Dosing: Case Studies in Pediatric Transplantation

2010-03-19T13:00:00Z

Instructor: William McGhee

Extreme Dosing in Overweight/Obese Children - Focus on DVT Prophylaxis

2010-03-19T13:00:00Z

Instructor: Peter Johnson

Extreme Dosing in CF: Aminoglycosides

2010-03-19T13:00:00Z

Instructor: Heidi Smith Hoopingarner

Hot Topics in Pediatric ID, Critical Care, and Nutrition

2009-09-27T13:00:00Z

Instructor: Jeff Cies, PharmD and Betsy Walter, PharmD

This program is a two hour Audio presentation synced with PowerPoint slides. The program contains three sections. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF documents for each section, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Medication Use During ECMO and Continuous Renal Replacement Therapy

2009-09-26T13:00:00Z

Instructor: Brenda Dodson

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Community-Acquired MRSA in Pediatric Patients

2009-09-26T13:00:00Z

Instructor: Kristin Klein, PharmD

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Management of Pediatric Chemical Casualties: Are We Prepared

2009-09-25T13:00:00Z

Instructor: Elora Hilmas

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Adolescents, Sexuality, and The Pediatric Pharmacist

2009-09-25T13:00:00Z

Instructor: Veenod Chulani

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.

Core Competency Series: Management of Diabetes Type 1

2009-09-24T18:00:00Z

Instructor: Michelle Condren

This program is a one hour Audio presentation synced with PowerPoint slides. To begin this program, please click the start icon below. You can follow along by downloading the handout below. To download the PDF document, please click the go button below. After completion of the program, you may take the post-test to receive credit.